drugset
Drugs / Human Mesenchymal Stem Cells
last change Apr 2023 re-read 3 minutes ago

Human Mesenchymal Stem Cells

also known as HMSC

Cell therapy

Developed for
Alzheimer disease
Investigated by
Bernard (Barry) Baumel

Trials 1

today NCT04040348 · Ph 1
2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT04040348 Oct 2019 → Apr 2023 Alzheimer disease Bernard (Barry) Baumel Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Human Mesenchymal Stem Cells “Multiple Allogeneic Human Mesenchymal Stem Cells (HMSC) Infusions” NCT04040348 ↗
Known as HMSC “Multiple Allogeneic Human Mesenchymal Stem Cells (HMSC) Infusions” NCT04040348 ↗
1

NCT04040348 ↗
Modality Cell therapy “Multiple Allogeneic Human Mesenchymal Stem Cells (HMSC) Infusions” NCT04040348 ↗
Route Intravenous “administered intravenously” NCT04040348 ↗